相关实验视频

Updated: May 9, 2025

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

通过全基因组测序分析扩大犬类扩散型大B细胞淋巴瘤遗传异常的谱

Antonella Fanelli¹, Eugenio Mazzone¹, Diana Giannuzzi²

¹Department of Veterinary Sciences, University of Turin, Grugliasco, Turin, Italy.

Veterinary and comparative oncology

|May 4, 2025

概括

全基因组测序确定了犬类扩散型大B细胞淋巴瘤 (DLBCL) 中的新型遗传变异. 这些发现可能解释了这种常见的狗癌症治疗反应和患者结果的差异.

科学领域:

兽医瘤学兽医瘤学
基因组学就是基因组学.
比較瘤學的相關搜尋

背景情况:

扩散性大B细胞淋巴瘤 (DLBCL) 是狗和人类常见的血液性恶性瘤.
狗DLBCL表现出显著的临床异质性和不良的预后可预测性.
下一代测序 (NGS) 已经对犬类DLBCL的理解有了很大的进步,但仍有许多无法解释的问题.

研究的目的:

调查犬类DLBCL治疗反应差异的分子基础.
确定与犬类DLBCL治疗结果相关的新型遗传变异.

主要方法:

10个犬类DLBCL病例的全基因组测序具有相似的临床病理特征,但结果各异.
根据淋巴瘤特异性存活率,将病例分为"差"和"好"的响应者.
分析蛋白质编码变异,拷贝数异常,拼接,UTR和内部变异.

主要成果:

识别新型候选基因,这些基因仅适用于反应不良或反应良好的人.
在已知反复突变基因中检测变异,包括拼接和内基变异.
扩大了涉及犬类DLBCL的潜在致病变体的范围.

结论:

基因组分析揭示了对犬类DLBCL异质性的分子驱动因素的新见解.
研究结果表明,潜在的遗传因素会影响狗DLBCL的化学免疫治疗反应.
需要在更大的队列中进一步验证,以确认这些遗传关联.

关键词:

DLBCL DLBCL 是一个字母.扩散的大B细胞淋巴瘤狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗狗预后预后预后整个基因组的测序.

更多相关视频

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....